Andy Watson

Andy Watson Email and Phone Number

Strategic Business Leader and Board Member @
Andy Watson's Location
Denver, Colorado, United States, United States
Andy Watson's Contact Details
About Andy Watson

Senior executive with verifiable year-after-year success achieving revenue, profit, product launch, and business growth objectives in start-up, small and large company environments with novel science. • Engaged with scientific founders: Worked to realize products and technology from first-in-class science, including 2 Nobel prize winners.• Successful Products: Extensive experience conceptualizing and commercializing integrated instrument-consumable-assay products, creating significant value in research, translational, CAP/CLIA, and regulated markets. • Driven and creative: A passion for commercial success through the integration of technology teams, differentiated products, launch strategy and customer needs. • Team builder and leader: Built and motivated global sales & field support, corporate marketing, product management, business development, engineering, bio-informatics and assay teams. • Business management: Managed high growth (>300%) and mature businesses (>$500 million annual revenue). Managed products from concept to launch to life cycle management.• Alliances and M&A: Sourced, nurtured, negotiated and managed strategic alliances with multi-national corporations, university labs, and commercial service organizations. Raised over $140 million from corporate partnerships, venture capital, debt, and government grants. Key player in M&A with deals up to $725 million. • Accomplished technologist: 16 patents and 10 peer-reviewed publications in next generation sequencing, hand-held diagnostic testing, digital PCR, microfluidics, and others. Author on seminal human genome and C. Elegans sequencing papers. Principal Investigator on several large grants and NIH reviewer.

Andy Watson's Current Company Details
1W Advisors

1W Advisors

Strategic Business Leader and Board Member
Andy Watson Work Experience Details
  • 1W Advisors
    Principal
    1W Advisors Apr 2018 - Present
    Board and CEO-level strategy, fundraising, investor diligence and consulting services. • Completed investor diligence projects on small companies focused on sequencing library preparation products; synthetic biology reagents and systems; and microfluidic single cell genomics sample preparation.• Completed go-to-market and product positioning project for board and CEO of a small company focused on cas-9 target enrichment for clinical sequencing. Interviewed ~15 key opinion leaders, identified unmet clinical needs, matched with technical capabilites, and created business plan. New strategic focus resulted.• Completed single cell genomics market assessment to identify investment opportunities for a life science tools investment fund. Interviewed ~20 practitioners and companies. Hosted think tank event with ~35 investors, practitioners, and small companies. Identified several new investment opportunities.• Completed project with CEO of a small company focused on long DNA molecules. Assessed clinical cytogenomics market, interviewed key opinion leaders, identified unmet needs, created business plan, and working to close venture funding. Funding closed and strategic direction set going forward.• Ongoing advisor with a small company focused on single cell isolation and culturing. Advising CEO on fundraising, company operations and strategic partnering.
  • Atrandi Biosciences | Droplet Genomics
    Chief Commercial And Business Officer (Interim) & Board Chair
    Atrandi Biosciences | Droplet Genomics Jun 2022 - Oct 2024
    Vilnius, Lithuania, Lt
    Atrandi is a Vilnius, LT growth-stage company with novel technologies for single cell genomics, microfluidics, and high throughput cell screening.• Closed seed ($5M) and series A venture funding with tier 1 US VC investor.• Managed/built global sales organization including creation of US subsidiary, 6 distribution partners, and implementation of sales management infrastructure. Grew sales >50% YoY.• Closed world class key opinion leader partnerships, demonstrating novel technology use-cases.• Built detailed business models, driven by extensive customer input.• Re-branded company and built marketing infrastructure, resulting in dramatic growth in awareness & sales leads.• Led board through critical strategic corporate decisions.• Nurtured and mentored key staff to take on new executive roles.• Built patent strategy resulting in early patent issuance and future broad technology protection.
    View
  • Empire Genomics, Llc
    Chief Executive Officer
    Empire Genomics, Llc Sep 2018 - May 2021
    Buffalo, Ny, Us
    • Hired by board and investors to assess and turn-around company. Divested clinical services business and non-core products; raised new funding; restructured debt; communicated with investors; resolved several significant balance sheet issues; drove company to sustained profitability increasing sales >20% YoY. Achieved >20% EBITDA.• Created and executing on focused product strategy to create up-side for investors and debt holders. Engaged directly with key customers. Aligned company around this strategy and re-energized the team. Restructured organization around new product focus.• Created 3-year strategic plan, annual operating plans and implemented operating mechanisms resulting in efficient operations and strong initial growth. Implemented new quality and regulatory systems.• Closed successful exit
    View
  • Genturi
    President & Ceo
    Genturi Sep 2016 - Apr 2018
    Led all aspects of company operations including strategy, hiring, alliances, licensing, budgeting, board meetings, legal, investor relations, branding, market analysis and commercial. Focus of company was on research management of a university-developed technology. Raised $8M series A funding. Created development alliances.
  • Cell Signaling Technology (Cst)
    Vice President Corporate Development
    Cell Signaling Technology (Cst) Aug 2014 - Sep 2016
    Danvers, Ma, Us
    Cell Signaling is a privately held bio-reagents company, employing ~500 worldwide. • Led company’s strategic planning, in conjunction with executive leadership, and worked to successfully communicate broadly to employee base.• Re-structured business development team leading to lower expenditure and alignment with objectives• Hired new diagnostics director and initiated building of a new CST diagnostics business focused on cancer and immuno-oncology opportunities• Managed a large portfolio of commercial and academic in-licenses• Led acquisitions process, including engagement of an external advisory group, leading to focus on a few key inorganic growth opportunities• Managed small corporate development team. Coached and motivated highly talented team members, turning around team morale and productivity.• Built strong relationships with many CST staff built on respect and integrity• Managed companion diagnostics and other corporate partnerships• Presented regularly to board of directors, employees, and partners
    View
  • Raindance Technologies
    Chief Commercial Officer
    Raindance Technologies May 2011 - Feb 2014
    Billerica, Ma, Us
    Acquired by Bio-Rad (NYSE:BIO) Raindance was a ~100-person microdroplet company, focused on genomics markets. Led sales, marketing, field applications, PR and business development. P&L responsibility for 2 business units and 3 global sales regions:- Revenue grew from $8.6M to $17.1M (2012 to 2013), and to $30.5M in 2014.- Launched 2 instrumentation platforms for clinical sequencing and digital PCR. Install base grew 206% in 2013.- Grew 'sticky' consumables business to around 25,000 samples per quarter at the end of 2013, up 300% from 2012 to 2013. This grew to 161,000 samples in 2014.- Nurtured and closed strategic deals, including Myriad Genetics, enabling Myriad's MyRisk inherited cancer genetic test. Deal generated ~$5M and >$15M in Raindance revenue (in 2013 and 2014 respectively), and also included significant fees and an equity investment.- Developed market for cancer DNA sequencing and liquid biopsy mutation detection, working directly with key opinion leaders worldwide- Restructured and re-built global sales team and closed 9 distribution agreements, while at the same time reducing marketing and sales expenses by ~10%.- Created customer advocacy programs and utilized these to transform web site, on-line marketing, and trade shows- Developed business plans and market analyses to support $20M series E equity and $35M debt financing- Presented regularly to board of directors, investors, customers, employees, press, and conferencesHired initially as Chief Marketing and promoted March 2013 to Chief Commercial Officer. At my promotion, the CEO wrote: "Thank you for your significant contributions to RainDance's growth and your leadership in Sales and Marketing during a period of organizational transition in 2012. You have brought stability, focus, energy and rhythm to our commercial organization and activities in the market."Note: information above is available from Raindance S-1 filing, www.raindancetech.com, and public presentations
    View
  • Life Technologies
    Vice President - Advanced Genetic Systems
    Life Technologies Mar 2008 - May 2011
    Waltham, Ma, Us
    Vice President – SOLiD Sequencing Product Management- Business responsibility for new product launches and ongoing business management of DNA detection and workflow instrumentation, reagents, and software for genome-scale sequencing- Re-aligned organization and implemented operating mechanisms to promote cooperation within the immediate and broader R&D, operations, and sales teams- Created and drove successful programs to turn-around customer experience, using net promoter score metric- Worked with R&D leadership to create customer segment focused applications, technology, and product roadmaps resulting in much improved organizational alignment and clarity- Led multi-disciplinary team in development of cancer applications and clinical/regulated product strategy – presented to executive leadership- Created detailed segment-specific 5-year financial plan for the business- Worked many multi-million dollar sequencing center deals with regional sales organizations, resulting in increased market share and notable wins in cancer centers- Created and managed to annual financial operating plan including revenue, gross margin, and fixed costs- Grew business at high annual percentage rate- Business lead for several M&A and licensing deals, including acquisition of Ion Torrent for up to $725M- Sought out and closed marketing and technology partnerships with small companiesVice President – Business Operations Single Molecule Sequencing - Performed extensive market analysis and customer interviews- Drove creation of technology and applications roadmap with R&D team- Presented to board of directors and CEO staff - significant program funding increase
    View
  • Life Technologies
    General Manager - Ce Sequencing Business
    Life Technologies Oct 2004 - Mar 2008
    Waltham, Ma, Us
    - Top line and margin responsibility for $550M genetic analysis business unit, including instrumentation, reagents and software products- Led product management, applications, and marketing teams.- Set selling strategy, trained sales teams and set sales targets and plans, with regional sales leaders- Worked with sales team to close many individual deals- Created re-furbished instrument program, increasing sales in the declining high throughput segment- Defined and led development of new regulated diagnostic DNA sequencing system (the ‘3500’ sequencer), including regulated instrumentation- Managed strategic partnership with Hitachi High Technologies- Created customer segment aligned business management organization leading to improved responsiveness to sales situations and better understanding of segment market drivers and customer needs- Implemented new product portfolio analysis system resulting in improved selection of future products- Championed use of Voice of Customer techniques within team leading to improved customer focusSr. Director – Market Development and Strategic Alliances- Led team charged with the technical, strategic and market analysis of next generation sequencing- Personally interviewed over 50 opinion leader customers to understand market potential and dynamics- Presented recommendations to executive management and board of directors, resulting in the $120M acquisition of SOLiD sequencing technology, then one of the 2 primary next generation sequencing competitors- Set up and managed early stage applications collaborations for next generation sequencing
    View
  • Quantum Dot Corporation
    Vp - Business Development
    Quantum Dot Corporation Nov 2000 - Oct 2004
    Us
    - Member of executive management team involved with all aspects of company management including goal setting, financial management, personnel, presentation to board of directors, etc.- Led the successful launch of the company’s first bio-reagent products including pre-launch market activities (commissioned primary market research, focus groups, beta testing, pricing, competitive analysis, sales forecasts), launch activities (e.g. marketing communications, internet marketing, trade shows, international distributor set up and management), and initial product roll out and marketing activities.- Initiated and led collaborations program with Genentech, GlaxoSmithkline, Astra Zeneca, Carnegie Mellon University, Cornell University, MIT, Harvard University, NIH, Melbourne andothers. Resulted in over 20 collaborator publications (e.g. Science, Nature Biotechnology) and recognition by Science as one of the top 10 scientific breakthroughs of 2003.- Closed multi-million dollar instrumentation deal with Panasonic, Japan.- Closed multi-million dollar deals with Ventana Medical Systems (now part of Roche) for clinical cytogenetics, and Affymetrix for microarray analysis. Several additional OEM deals.- Led executive team’s strategy development projects.- Negotiated (with company President) $5MM venture debt facility.- Managed Quantum Dot’s federal grant program, resulting in approx. $10 million in federal grant funding.- Initiated and led public relations efforts. Significant coverage in trade, national business, and local press, including recognition as Forbes magazine’s #1 ‘Cool Company’.- Managed university IP licenses.
    View
  • Quantum Dot Corporation
    Vp Systems Engineering
    Quantum Dot Corporation Nov 1998 - Nov 2000
    Us
    - Led team that developed bio-system instrument prototype, commercialized in collaboration with Panasonic.- Wrote major technical and market sections of the business plans for the first ($7.5 million) and second ($30 million) VC financing rounds and presented the company to investors, with CEO.- Principal investigator on $14MM federal grant for diagnostic testing of blood markers.- Inventor on several single molecule and bio-detection patents. As part of the 3-person patent committee, oversaw patent strategy for the company, resulting in an extensive patent estate with broad scope.
    View
  • Sequana Therapeutics
    Director - Genomics Technologies
    Sequana Therapeutics Nov 1994 - Oct 1998
    Job titles were: Director of Genomics Technology, Director of Engineering and Information Systems, Associate Director of Engineering, Group leader – automation systems, Senior Systems Engineer- Grew and managed molecular biology, biochemistry, bio-informatics, and automation teams.- Set up large scale systems for automation of genotyping and sequencing processes resulting in a dramatic improvement in production quality and efficiency – 32 systems in constant use.- Invented a novel method for the synthesis and analysis of oligonucleotide arrays for genetic analysis. Principal Investigator on a federal grant for a $15MM program to further develop this system.
  • Sanger Center
    Group Leader - Engineering
    Sanger Center Sep 1990 - Jul 1994
    Reported to Nobel prize winner John Sulston- Start-up scientist at The Sanger Centre, now one of the main human genome sequencing centers.- Developed automation systems for large-scale genome sequencing projects- Wrote image analysis, instrument control, and user interfaces for automation systems.- Transferred robotics and automation technology to Genomic Solutions Inc. for commercialization.- Founded Automation in Mapping and Sequencing conference, now part of AGBT

Andy Watson Skills

Genomics Biotechnology Commercialization Product Management Dna Sequencing Life Sciences Lifesciences Sequencing Molecular Biology Genetics Business Development Oncology Biochemistry Technology Transfer Strategy R&d Product Launch Genotyping Market Development International Sales Product Development Sales Management Executive Management Business Planning Hardware Diagnostics Cross Functional Team Leadership Start Ups Assay Development Research And Development Bioinformatics Marketing Strategy Commercial Management Product Strategy Product Requirements Definition Business Plan Formulation Strategic Partnerships

Andy Watson Education Details

  • University Of Cambridge
    University Of Cambridge
    Business

Frequently Asked Questions about Andy Watson

What company does Andy Watson work for?

Andy Watson works for 1w Advisors

What is Andy Watson's role at the current company?

Andy Watson's current role is Strategic Business Leader and Board Member.

What is Andy Watson's email address?

Andy Watson's email address is an****@****ics.com

What is Andy Watson's direct phone number?

Andy Watson's direct phone number is +178186*****

What schools did Andy Watson attend?

Andy Watson attended University Of Cambridge.

What are some of Andy Watson's interests?

Andy Watson has interest in Children, Education, Science And Technology, Human Rights, Arts And Culture, Health.

What skills is Andy Watson known for?

Andy Watson has skills like Genomics, Biotechnology, Commercialization, Product Management, Dna Sequencing, Life Sciences, Lifesciences, Sequencing, Molecular Biology, Genetics, Business Development, Oncology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.